F2 and glioma: In the Vienna Cancer and Thrombosis study it was found that, in high-grade, podoplanin-expressing gliomas, peripheral blood parameters were also significantly affected (lower blood platelet count, higher level of Factor VIII acitivity and higher prothrombin fragment 1 + 2).